| Primary |
| Hyperthyroidism |
32.6% |
| Basedow's Disease |
22.5% |
| Thyroid Disorder |
9.1% |
| Breast Cancer |
5.3% |
| Migraine |
4.3% |
| Glaucoma |
3.2% |
| Goitre |
3.2% |
| Malignant Melanoma |
2.7% |
| Completed Suicide |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Autoimmune Thyroiditis |
1.6% |
| Endocrine Ophthalmopathy |
1.6% |
| Neck Pain |
1.6% |
| Tachycardia |
1.6% |
| Asthma |
1.1% |
| Atrial Fibrillation |
1.1% |
| Back Pain |
1.1% |
| Constipation |
1.1% |
| Contraception |
1.1% |
| Convulsion |
1.1% |
|
| Weight Increased |
9.1% |
| Exomphalos |
7.6% |
| Headache |
7.6% |
| Drug Exposure During Pregnancy |
6.1% |
| Drug Ineffective |
6.1% |
| Thrombocytopenia |
6.1% |
| Tri-iodothyronine Increased |
6.1% |
| Ageusia |
4.5% |
| Alopecia |
4.5% |
| Dysgeusia |
4.5% |
| Pyrexia |
4.5% |
| Rash Generalised |
4.5% |
| Stevens-johnson Syndrome |
4.5% |
| Vomiting |
4.5% |
| White Blood Cell Count Decreased |
4.5% |
| Agranulocytosis |
3.0% |
| Breast Cyst |
3.0% |
| Hypoaesthesia Oral |
3.0% |
| Increased Upper Airway Secretion |
3.0% |
| Irritability |
3.0% |
|
| Secondary |
| Hyperthyroidism |
27.8% |
| Thyroid Disorder |
16.9% |
| Product Used For Unknown Indication |
9.3% |
| Endocrine Ophthalmopathy |
7.6% |
| Basedow's Disease |
6.8% |
| Gastrooesophageal Reflux Disease |
3.8% |
| Atrial Fibrillation |
3.0% |
| Blood Pressure Abnormal |
3.0% |
| Glaucoma |
2.5% |
| Acute Tonsillitis |
2.1% |
| Autoimmune Thyroiditis |
2.1% |
| Breast Cancer |
2.1% |
| Hypertension |
2.1% |
| Drug Use For Unknown Indication |
1.7% |
| Migraine |
1.7% |
| Palpitations |
1.7% |
| Smoking Cessation Therapy |
1.7% |
| Vitamin Supplementation |
1.7% |
| Agitation |
1.3% |
| Graves' Ophthalmopathy |
1.3% |
|
| Product Tampering |
11.6% |
| Tri-iodothyronine Increased |
10.5% |
| Product Packaging Issue |
9.3% |
| Weight Increased |
9.3% |
| Headache |
7.0% |
| Completed Suicide |
4.7% |
| Malaise |
4.7% |
| Paraesthesia |
4.7% |
| Rhabdomyolysis |
4.7% |
| Thyroid Function Test Abnormal |
4.7% |
| Urticaria |
4.7% |
| Cardio-respiratory Arrest |
3.5% |
| Feeling Abnormal |
3.5% |
| Self Injurious Behaviour |
3.5% |
| Adverse Event |
2.3% |
| Alopecia |
2.3% |
| Breast Cyst |
2.3% |
| Hepatitis Cholestatic |
2.3% |
| Incorrect Dose Administered |
2.3% |
| Increased Upper Airway Secretion |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.1% |
| Hypertension |
10.5% |
| Hyperthyroidism |
9.1% |
| Atrial Fibrillation |
6.2% |
| Drug Use For Unknown Indication |
6.0% |
| Diabetes Mellitus |
4.9% |
| Chronic Obstructive Pulmonary Disease |
4.2% |
| Crohn's Disease |
3.2% |
| Multiple Myeloma |
2.9% |
| Pain |
2.9% |
| Blood Cholesterol Increased |
2.7% |
| Anxiety |
2.4% |
| Insomnia |
2.4% |
| Thyroid Disorder |
2.3% |
| Nuclear Magnetic Resonance Imaging |
2.2% |
| Rheumatoid Arthritis |
2.2% |
| Colorectal Cancer Metastatic |
2.0% |
| Depression |
2.0% |
| Headache |
2.0% |
| Mastocytosis |
1.9% |
|
| Weight Decreased |
8.7% |
| White Blood Cell Count Increased |
7.8% |
| Pain In Extremity |
6.8% |
| Hypoglycaemia |
5.8% |
| Nausea |
5.8% |
| Diarrhoea |
4.9% |
| Hypotension |
4.9% |
| Pain |
4.9% |
| Pyrexia |
4.9% |
| Rash |
4.9% |
| Vomiting |
4.9% |
| White Blood Cell Count Decreased |
4.9% |
| Cerebrovascular Accident |
3.9% |
| Hyperthyroidism |
3.9% |
| Oedema |
3.9% |
| Rash Generalised |
3.9% |
| Skin Disorder |
3.9% |
| Thyroid Cancer |
3.9% |
| Transient Ischaemic Attack |
3.9% |
| Tremor |
3.9% |
|
| Interacting |
| Hyperthyroidism |
33.3% |
| Prophylaxis |
33.3% |
| Atrial Fibrillation |
16.7% |
| Tachycardia |
16.7% |
|
| International Normalised Ratio Abnormal |
33.3% |
| International Normalised Ratio Increased |
33.3% |
| Jaundice |
33.3% |
|
